This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Croatia to pay for early-stage Herceptin. Scrip: 8, No. 3246, 30 Mar 2007
About this article
Cite this article
The Croatian government is to pay for early-stage human epidermal growth factor receptor 2-positive breast cancer patients to receive Roche's Herceptin. Pharmacoecon. Outcomes News 526, 11 (2007). https://doi.org/10.2165/00151234-200705260-00025
- Public Health
- Breast Cancer
- Health Outcome
- Human Epidermal Growth Factor Receptor